Bacainn Therapeutics Presents Data on BT051 at ECCO ‘21
09 Jul 2021 //
BUSINESSWIRE
Bacainn Therapeutics reports positive data from ulcerative colitis trial
03 Dec 2020 //
CLINICALTRIALSARENA
Bacainn Therapeutics Reports Positive Topline Results from Ph1 Study of BT051
02 Dec 2020 //
BUSINESSWIRE
Bacainn Reports Positive Topline Results from Phase 1 Study of BT051
02 Dec 2020 //
BUSINESSWIRE

Market Place
Sourcing Support